Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Dyskinesia and brain-derived neurotrophic factor levels after long-term levodopa and nicotinic receptor agonist treatments in female mice with near-total unilateral dopaminergic denervation.
BMC Neurosci. 2018 Nov 29;19(1):77. doi: 10.1186/s12868-018-0478-0.
BMC Neurosci. 2018.
PMID: 30497382
Free PMC article.
Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Leino S, Koski SK, Hänninen R, Tapanainen T, Rannanpää S, Salminen O.
Leino S, et al. Among authors: rannanpaa s.
Neuropharmacology. 2018 Aug;138:371-380. doi: 10.1016/j.neuropharm.2018.06.028. Epub 2018 Jun 22.
Neuropharmacology. 2018.
PMID: 29940207
Free article.
Item in Clipboard
Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
Koski SK, Leino S, Panula P, Rannanpää S, Salminen O.
Koski SK, et al. Among authors: rannanpaa s.
Neurosci Lett. 2020 Jun 11;729:134932. doi: 10.1016/j.neulet.2020.134932. Epub 2020 Mar 26.
Neurosci Lett. 2020.
PMID: 32224226
Free article.
Item in Clipboard
Effects of antidyskinetic nicotine treatment on dopamine release in dorsal and ventral striatum.
Leino S, Koski SK, Rannanpää S, Salminen O.
Leino S, et al. Among authors: rannanpaa s.
Neurosci Lett. 2018 Apr 13;672:40-45. doi: 10.1016/j.neulet.2018.02.042. Epub 2018 Feb 21.
Neurosci Lett. 2018.
PMID: 29474871
Item in Clipboard
Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.
Kopra J, Villarta-Aguilera M, Savolainen M, Weingerl S, Myöhänen TT, Rannanpää S, Salvatore MF, Andressoo JO, Piepponen TP.
Kopra J, et al. Among authors: rannanpaa s.
Neuropharmacology. 2018 Jan;128:221-230. doi: 10.1016/j.neuropharm.2017.10.010. Epub 2017 Oct 13.
Neuropharmacology. 2018.
PMID: 29031851
Free PMC article.
Item in Clipboard
Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland - a matched cohort study.
Taipale H, Lähteenvuo M, Tanskanen A, Huoponen S, Rannanpää S, Tiihonen J.
Taipale H, et al. Among authors: rannanpaa s.
BMC Psychiatry. 2022 Jul 19;22(1):484. doi: 10.1186/s12888-022-04115-7.
BMC Psychiatry. 2022.
PMID: 35854248
Free PMC article.
Item in Clipboard
Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study.
Lähteenvuo M, Taipale H, Tanskanen A, Rannanpää S, Tiihonen J.
Lähteenvuo M, et al. Among authors: rannanpaa s.
J Affect Disord. 2022 Jul 1;308:236-242. doi: 10.1016/j.jad.2022.04.010. Epub 2022 Apr 6.
J Affect Disord. 2022.
PMID: 35398108
Free article.
Item in Clipboard
Cite
Cite